Balance Therapeutics
is a clinical-stage pharmaceutical company developing therapies to improve the lives of patients with debilitating neurological conditions. We focus on areas of high unmet medical need where neurobiological pathways provide a strong rationale for our pharmacological approach. Our experienced drug development team is committed to advancing products to deliver life-improving medicines that serve patients and their families. Our principal areas of focus are sleep disorders and cognitive deficits. Learn more below.
Balance Therapeutics has raised three rounds of private financing. Investors include Mohr Davidow Ventures, Oakmont Corporation, Orbimed Advisors, Rock Springs Capital, and Pappas Ventures. The company has also received significant R&D support from the U.S. National Institutes of Health.
Clinical Trial Information
Learn more about our science and clinical plans